Germany will limit the use of AstraZeneca’s COVID-19 vaccine to people aged 60 and above as well as high-priority groups following further reports of cerebral sinus vein thrombosis (CSVT). 

Acting on advice from Germany’s vaccine committee, known as STIKO, its federal and state health ministries agreed under-60 year olds should only receive the AstraZeneca vaccine if they belong to high-priority groups, which include high-risk patients and medical workers, in consultation with a doctor.